Investigator Initiated Research
Investigator-initiated research involving interventional treatment on human subjects is a valuable component to the academic and research initiatives of the Drexel University. This research is unique in that the investigator serves not only as the principal investigator but also the sponsor. Thus, the researcher can expect a higher level of preparation, consideration, and responsibilities. In addition, Drexel University must also assume a higher level of responsibility and risk as the institution housing such research. Researchers should also expect to meet additional institutional requirements based on the nature of the research.
In support of our investigators and their protocols of this design, Drexel has formed the Investigator Initiated Study Advisory (IISA) committee to assist and guide investigators through a review process in advance of, and support of IRB application. The Investigator-Initiated Study Advisory Committee (IISA Committee) is a group consisting of Drexel University members from various administrative departments (i.e. Clinical Research Group, Human Research Protection, Office of General Counsel).
The IISA Committee was established to provide researchers an early assessment of their research to identify additional regulatory and institutional requirements imposed on such research. The early assessment will allow researchers to plan for these additional requirements. In addition, the early assessment will also allow Drexel, as the research institution, to conduct a risk and cost analysis. Such early assessment is aimed to reduce the delays in initiating such research.
If you would like to arrange an IISA review or speak with the team please contact the IISA at 215-255-7382, email@example.com.